A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
Sign Up to like & getrecommendations! Published in 2017 at "Antiviral Research"
DOI: 10.1016/j.antiviral.2017.10.015
Abstract: ABSTRACT Infections with hepatitis C virus (HCV) represent a worldwide health burden and a prophylactic vaccine is still not available. Liver transplantation (LT) is often the only option for patients with HCV‐induced end‐stage liver disease.… read more here.
Keywords: human monoclonal; mab 2a5; hcv; virus ... See more keywords